The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J05 | Antivirals for systemic use | |
| 3 | J05A | Direct acting antivirals | |
| 4 | J05AR | Antivirals for treatment of HIV infections, combinations | |
| 5 | J05AR21 | Dolutegravir and rilpivirine |
| Active Ingredient | Description | |
|---|---|---|
| Dolutegravir and Rilpivirine |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| DALIDUO Film-coated tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| JULUCA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.